Stockholders’ Deficit - Schedule of Stock Options Roll Forward (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Apr. 30, 2025	Jan. 31, 2025
Number of Options
Outstanding, beginning of period (in shares)	9,570,134
Granted (in shares)	0
Exercised (in shares)	(197,534)
Cancelled (in shares)	0
Outstanding, end of period (in shares)	9,372,600	9,570,134
Options vested, number of options (in shares)	2,659,733
Options exercisable, number of options (in shares)	2,659,733
Weighted- Average Exercise Price
Outstanding, beginning of period (in USD per share)	$ 27.80
Granted (in USD per share)	0
Exercised (in USD per share)	9.49
Cancelled (in USD per share)	0
Outstanding, end of period (in USD per share)	28.19	$ 27.80
Options vested, weighted average exercise price per share (in USD per share)	18.62
Options exercisable, weighted average exercise price per share (in USD per share)	$ 18.62
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term	8 years 1 month 6 days	8 years 2 months 12 days
Options vested, weighted average remaining contractual term	5 years 10 months 24 days
Options exercisable, weighted average remaining contractual term	5 years 10 months 24 days
Options outstanding, aggregate intrinsic value	$ 396,854	$ 435,133
Options exercised, aggregate intrinsic value	9,955
Options exercisable, aggregate intrinsic value	138,054
Options vested, aggregate intrinsic value	$ 138,054